Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Chinese investigators divulge P2X3 receptor antagonists

July 6, 2021

DiaMedica reports interim phase II data on DM-199 in chronic kidney disease

June 29, 2021

FDA clears IND for clinical evaluation of CLBS-201 for diabetic kidney disease

June 23, 2021

Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors

June 14, 2021

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

June 11, 2021

Nippon Shinyaku patents muscarinic acetylcholine M3 receptor positive allosteric modulators

June 9, 2021

BI-655064 does not meet CRR primary endpoint in lupus nephritis phase II trial

June 4, 2021

Pivotal study of venglustat in ADPKD stopped for futility

June 1, 2021

Targeting senescent cells restores kidney function

May 26, 2021

Regulus reports updated results from phase Ib study of RGLS-4326 in ADPKD

May 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...